BIOTECHNICA is regarded as the leading event of the year for the European biotech industry, covering all sectors of biotechnology in depth - from basic biotechnology research, equipment, bioinformatics and services to the five principal areas of application - pharmaceuticals and medicine, industry, nutrition, agriculture and the environment.

During the BIOTECHNICA Show (Oct. 9th ~11th, 2007), Medigreen will display the achievement on new botanical drug development and novel nutraceutical formulations. New drug development focused on “alleviating the side effects of cancer chemo-radiotherapy (CA-88)”, “preventing and curing the digestive ulcer (MIC-31)”, and “asthma controlling (1217B)” , whereas CA-88, MIC31, and 1217B have been successfully developed into functional foods LeukoUp, HF-899, and MAF, respectively.

Besides, Medigreen will launch new nutraceutical formulation for “vision care (Eyebright Mix)” and “health weight control (MT4)” in Europe. On July 26th, 2007, Medigreen signed an agreement with Kyoko, Japan-based SOHARD company to supply MT4 formulation in ingredient form for use in a SOHARD product for the Japan market with a deal worth NT$300 million (US$9 million).

For more detailed information about Medigreen’s new drugs and nutraceutical formulation, welcome to our booth during the BIOTECHNICA Show period.

Show date: October 9 – 11, 2007
Opening hours:9 a.m. to 6 p.m.
Booth No.: G16-F, Hall 9th
Show venue: Messegelaende. Exhibition Grounds, 30521 Hannover, Germany